Источники. 1. Seitz, J.L.,The Politics of Development, New York, Basil Blackwell, 1988, p47.

1. Seitz, J.L., The Politics of Development, New York, Basil Blackwell, 1988, p47.

2. Latham, M.C., "Protein-energy malnutrition - its epidemiology and control", JEPTO, Vol 10, No 4-5, Jul-Oct 1990, pp168-180.

3. Anon., "The backdrop of poverty, disease and debt", New Scientist, 17 Feb 1990, p41.

4. UNICEF, The State of the World's Children 1990, Oxford and New York, Oxford University Press, 1989, p27.

5. Kusin, J.A., Kardjati, S., et al, "Energy supplementation during pregnancy and postnatal growth", Lancet, Vol 340, 12 Sep 1992, pp623-6.

6. Grantham-McGregor, S.M., Powell, C.A., et al, "Nutritional supplementation, psychosocial stimulation, and mental development of stunted children: the Jamaican study", Lancet, Vol 338, 6 Jul 1991, pp1-5.

7. Seitz, op cit, p52.

8. UNICEF, The State of the World's Children 1991, Oxford and New York, Oxford University Press, 1990, p10.

9. UNICEF, WHO and UNESCO, Facts for Life: A Communication Challenge, New York, UNICEF, 1989, p5.

10. Macdonald, J.J., Primary Health Care: medicine in its place, London, Earthscan, 1993, p21.

11. Pryer, J. and Crook, N., Oxford, Oxfam, 1988, p11.

12. UNICEF, 1989, op cit, p31.

13. UNICEF, WHO and UNESCO, op cit, pp28-9.

14. Leisinger, K.M., Poverty, Sickness and Medicines: an unholy alliance?, Geneva, IFPMA, 1989, p23.

15. Kennedy, I., The Unmasking of Medicine, London, Paladin, 1983, p23.

16. Muller, M., The Health of Nations, London, Faber & Faber, 1982, p35.

17. Macdonald, op cit, p46.

18. Cited in: McKeown, Т., "The road to health", World Health Forum, Vol 10, No 3/4,1989, pp408-16.

19. UNICEF, 1989, op cit, p29.

20. UNICEF, The State of the World's Children, 1989, Oxford and New York, Oxford University Press, 1988, p46.

21. UNICEF, 1990, op cit, p10.

22. Medawar, C. and Gilbert, D., Double Standards, London/The Hague, Social Audit/IOCU, 1985.

23. Daniel, Т., Appetite Stimulants for Children in Developing Countries? Experts say DON’T!, London, Social Audit, 1986, p2.

24. Social Audit, press release, Social Audit Calls For Withdrawal of Appetite Stimulants, London, 24 June 1985.

25. AMA, Drug Evaluations, Chicago, (5th edn) 1983, p1478.

26. Henry, J.(ed.), The British Medical Association Guide to Medicines & Drugs, London, Dorling Kindersley, (2nd edn) 1991, p346.

27. Reynolds, J.E.F. (ed.), Martindale: The Extra Pharmacopoeia, London, The Pharmaceutical Press, (29th edn) 1989, pp443, 451, 458-9.

28. Laurence, D.R. and Bennett, P.N., Clinical Pharmacology, Edinburgh, Churchill Livingstone, (6th edn), 1987, p365.

29. Medawar and Gilbert, op cit, p2.

30. Daniel, op cit, p2.

31. Anon., "Cyproheptadine (Periactin)", The Medical Letter on Drugs and Therapeutics, Vol 5, No 3, 5 Mar 1971.

32. BMA and the Royal Pharmaceutical Society of Great Britain, British National Formulary, London, BMA and The Pharmaceutical Press, No 23, Mar 1992, p122.

33. MIMS Africa, Jul 1991, p106.

34. Anon., "Merck & Co stops promoting Periactin", Scrip, No 1101, 12 May 1986, p7.

35. Quijano, R., "Vitamins, tonics and appetite stimulants", The Drug Monitor, Vol VI, No 8/9, Aug/Sep 1991, pp74-7.

36. Anon., "Appetite stimulant withdrawn", HAI News, No 61, Oct 1991, p3;Anon., HAI International Meeting Report, Amsterdam, HAI-Europe, 1993, p11.

37. BMA and the Royal Pharmaceutical Society of Great Britain, op cit, p344.

38. CIMS, Sep-Dec 1989, p12.

39. Rylance, G. (ed.), Drugs for children, Copenhagen, WHO, 1987, p48.

40. Gilman, A.G., Rail, T.W., Nies, A.S., and Taylor, P. (eds), Goodman and Gilman's The Pharmacological Basis of Therapeutics, New York, Pergamon Press, (8th edn) 1990, pp1423-7.

41. Ibid.

42. AMA, Drug Evaluations, Philadelphia, W.B. Saunders Co., (6th edn) 1986, pp680-1, 699.

43. IFPMA, IFPMA Code of Pharmaceutical Marketing Practice: Status Report March 1984, Geneva, EFPMA, Apr 1984, p3.

44. WEMOS, Organon and anabolic steroids, Amsterdam, 1987, p6.

45. Gilman, et al, op cit.

46. Parish, P., Medicines: a guide for everybody, London, Penguin (6th edn, revised), 1989, p226.

47. AMA, 1986, op cit, pp680-1, 699.

48. Gilman, et al, op cit.

49. Ibid.

50. Dukes, M.N.G. and Beeley, L., (eds), Side Effects of Drugs Annual 14, Amsterdam, Elsevier, 1990, p360.

51. Gilman, et al, op cit; Dukes and Beeley, op cit 51a. AMA, op cit., pp 741-2 and 74708..

52. Gilman, et al, op cit.

53. Geddes, J.A., "Anabolic steroids and the athlete", Canadian Family Physician, Vol 37, Apr 1991, pp979-83.

54. Gilman, et al, op cit.

55. AMA, 1986, op cit, pp680-1, 699.

56. Silverman, M., Lydecker, M. and Lee, P.R., Bad Medicine: the prescription drug industry in the Third World, Stanford, Stanford University Press, 1992, pp39-40, 313, 315.

57. See: MIMS Africa, Jan 1991, p140; or MIMS Middle East, Dec 1990, p140, for example.

ЭНДРЮ ЧЕТЛИ. ПРОБЛЕМНЫЕ ЛЕКАРСТВА ЭНДРЮ ЧЕТЛИ. ПРОБЛЕМНЫЕ ЛЕКАРСТВА

Содержание:: ANTIBIOTIC.ru

Дата добавления: 2015-07-17